System and method for in-vivo hematocrit measurement using impedance and pressure plethysmography
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 3, 2000
Issued Date -
N/A
app pub date -
Jul 23, 1998
filing date -
Oct 4, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The hematocrit of blood (i.e., the percentage of whole blood volume occupied by red blood cells) perfusing a finger is determined by stimulating the finger with two current frequencies, one relatively high (e.g., 10 MHZ) and the other relatively low (e.g., 100 KHz). Voltages induced in the finger in response to the two current frequencies are then captured and separated into baseline and pulsatile components. The hematocrit is determined as a function of the ratio of the high frequency pulsatile component to the low frequency pulsatile component, multiplied by the ratio of the square of the low frequency baseline component to the square of the high frequency baseline component. The signal-to-noise ratio of the captured voltages can be enhanced by the application of external pressure to the finger, such as by applying a pressure cuff to the finger.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully